Gliomas are the most invasive brain tumors characterized by high mortality and recurrence
ratesMukhametov, U.F.,
Lyulin, S.V.,
Borzunov, D.Y.,
Gareev, I.F.,
Beylerli, O.A.,
Sufianov, A.A. (2022) for rhBMPs, the
rates of adverse effects related to HO range from 1 % to 10 %. However, to date